Delisting risk
N2OFF
Develops mitochondrial transporter drug candidates and European solar and storage projects.
$1.78
After-hours close−0.06 (−3.26%)
At close$1.84(−3.66%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 28.43%Insiders —
Shares outstanding 56.6K · Float 23.4K
Insiders — no current Form 4 position.
This issuer lists more than one class and the share count spans them all, so a stake here reads as a share of the whole company, not of this class.
Institutions13F, as of Mar 31, 2026
8 holders · 16.1K shares · 8 new positions · 8 increased · 0 reduced · 0 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 7.1K | 12.58% | +7.1Knew | May 15, 2026 |
| XTX Topco Ltd | 3.1K | 5.49% | +3.1Knew | May 15, 2026 |
| Yorkville Advisors Global, LP | 2.3K | 4.14% | +2.3K | May 13, 2026 |
| UBS Group AG | 1.9K | 3.31% | +1.6K | May 5, 2026 |
| Vanguard Fiduciary Trust Co | 998 | 1.76% | +998new | May 8, 2026 |
| Tower Research Capital LLC (TRC) | 643 | 1.14% | +504 | May 15, 2026 |
| Morgan Stanley | 1 | 0.00% | 0 | May 15, 2026 |
| Caitong International Asset Management Co., Ltd | 0 | 0.00% | 0new | May 11, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | Filed |
|---|---|---|---|
| Lee Eun Young | 10 percent owner | 68.5K | Mar 26, 2026 |
1 ten-percent owner holds 68.5K shares by Form 4, outside the officers-and-directors figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jan 29, 2026 | Eun Young Lee10 percent owner | Sale | 127 | $1.36 | 479,524 |
CongressHouse and Senate disclosures
Not reported.